Taejoon Introduced New Ethical Products for Ophthalmologic and Gastric Disorders

Published: 2005-01-13 06:58:00

Updated: 2005-01-13 06:58:00

Taejoon Pharmaceutical has recently made an introduction of new ethical products in two therapeutic areas of retinopathy and gastric ulcer, to be launched in the domestic market under an aggressive marketing promotion plan.

For treatment of diabetic and hypertensive retinopathy (gradual breakd...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK